S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Genesis MedTech Secures CE Mark for 8 mm High-Definition Endoscope

Singapore-based Genesis MedTech has secured CE Mark approval for its 8 mm video endoscope, overcoming a significant engineering hurdle in surgical visualization. The device packs 3D imaging, 4K resolution, and fluorescence capabilities into a compact frame previously limited to larger 10 mm instruments, promising greater versatility for minimally invasive procedures.

Genesis MedTech Secures CE Mark for 8 mm High-Definition Endoscope
Photo: Bio & News

Miniaturizing high-end optical, electronic, and mechanical systems into an 8 mm diameter represents a technical breakthrough for surgeons performing complex operations. By reducing the footprint of the hardware, the device allows for smoother navigation across multiple anatomical regions, such as during a nephroureterectomy where surgeons must transition between the upper abdomen and pelvis.

The endoscope’s design includes configurable system interfaces, allowing it to integrate seamlessly into diverse surgical platforms. This regulatory clearance broadens the company’s imaging portfolio and highlights a push toward more agile, less invasive surgical tools. Genesis MedTech, which maintains operations ranging from R&D to commercialization, intends to deploy this technology to improve outcomes in vascular, cardiology, and general surgical specialties.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!